Table 1.
Reasons for withdrawal from trial of oral and vaginal lactobacillus for preventing post-antibiotic vulvovaginitis among 278 women and levels of poor compliance. Values are numbers of women
Treatment group
|
||||
---|---|---|---|---|
Withdrawal and compliance | Oral and vaginal lactobacillus (n=67) | Oral lactobacillus and vaginal placebo (n=73) | Oral placebo and vaginal lactobacillus (n=70) | Oral and vaginal placebo (n=68) |
Withdrawal from trial, reasons: | 7 | 9 | 9 | 13 |
Unknown | 2 | 2 | 4 | 5 |
Forgot treatment | 2 | 0 | 0 | 3 |
Lost interest | 1 | 1 | 2 | 1 |
Too sick | 1 | 1 | 1 | 2 |
Moved from area | 1 | 2 | 0 | 0 |
Death in family | 0 | 1 | 2 | 1 |
Side effects | 0 | 1 | 0 | 0 |
Stopped antibiotics | 0 | 1 | 0 | 1 |
Poor compliance (took less than half of treatment): | ||||
Antibiotic | 1 | 1 | 0 | 1 |
Oral intervention | 5 | 2 | 2 | 5 |
Vaginal intervention | 9 | 6 | 7 | 4 |